Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.6790
+0.0184 (2.79%)
Oct 2, 2026, 2:39 PM EDT - Market open
Envoy Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -23.4 | -23.76 | -20.8 | -29.92 | -15.92 | -8.68 |
Depreciation & Amortization | 0.3 | 0.3 | 0.17 | 0.13 | 0.08 | 0.07 |
Other Amortization | 0.93 | 0.96 | 1.05 | 0.6 | - | - |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0 |
Stock-Based Compensation | 0.97 | 0.75 | 0.56 | 1.58 | - | - |
Other Operating Activities | 0.26 | 1.71 | 1.7 | 11.5 | 7.2 | 1.75 |
Change in Accounts Receivable | -0.01 | 0 | 0.03 | -0.03 | 0.05 | -0.02 |
Change in Inventory | -0.04 | 0.13 | -0.38 | -0.01 | -0.19 | 0.06 |
Change in Accounts Payable | 0.51 | 1.39 | -0.02 | 0.55 | 0.34 | 0.23 |
Change in Other Net Operating Assets | -1.05 | 0.32 | -0.27 | -1.5 | -0.36 | -0.35 |
Operating Cash Flow | -21.53 | -18.2 | -17.95 | -17.09 | -8.81 | -6.94 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.18 | -0.18 | -0.98 | -0.15 | -0.22 | -0.13 |
Investing Cash Flow | -0.18 | -0.18 | -0.98 | -0.15 | -0.22 | -0.13 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 10 | 20 | 10 | 8 | 8 |
Long-Term Debt Repaid | - | -0.93 | -0.92 | -0.56 | - | - |
Net Debt Issued (Repaid) | -0.88 | 9.07 | 19.08 | 9.44 | 8 | 8 |
Issuance of Common Stock | 36.92 | 7.1 | 1.75 | 0.11 | - | - |
Preferred Dividends Paid | - | -1.82 | -2.45 | - | - | - |
Dividends Paid | - | -1.82 | -2.45 | - | - | - |
Other Financing Activities | 0.07 | 2.28 | 1.82 | 11.74 | 0.09 | 0.06 |
Financing Cash Flow | 36.11 | 16.63 | 20.2 | 21.28 | 8.09 | 8.06 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0 | 0 | -0.01 | -0 | -0.01 | -0.01 |
Net Cash Flow | 14.39 | -1.74 | 1.26 | 4.04 | -0.94 | 0.99 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -21.71 | -18.38 | -18.93 | -17.24 | -9.02 | -7.06 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -10488.41% | -7626.56% | -8412.89% | -5456.96% | -3807.17% | -2277.74% |
Free Cash Flow Per Share | -0.39 | -0.79 | -1.01 | -1.40 | -0.89 | -0.70 |
Levered Free Cash Flow | -8.22 | -8.1 | -11.65 | -5.91 | -5.17 | - |
Unlevered Free Cash Flow | -7.93 | -7.1 | -11.14 | -5.91 | -5.17 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.03 | 0.04 | 0.04 | - | - | - |
Change in Working Capital | -0.6 | 1.84 | -0.64 | -0.98 | -0.16 | -0.08 |